Island Labs Announces Health Canada approval for Stemcelex and Appoints Lorne
Meikle as Board Chair
In the
Island Labs is also pleased to announce that Lorne Meikle has been appointed board chair at Island Labs. He will direct the global licensing and commercialization of Stemcelex. "Stemcelex research indicates that this innovative new product offers significant hair growth improvement over currently marketed products," Meikle said. Meikle was a member of senior management teams at industry leaders: Glaxo
Having served as CEO for nine biotechnology companies, Meikle is currently president and CEO of Management Dynamics Ltd., a biotechnology and water resources firm; LOB Ordeins Inc., a human therapeutics delivery company and CEO of Neuroimage Inc. He is also chairman and director of Quest PharmaTech Inc. (TSXV-QPT).
Meikle has more than four decades of experience in executive management in health-care and joins Island Labs in their commitment to enhancing the quality of life by developing and delivering safe and effective dermatological products.
For further information: Robert Tulk, (709) 634-2724, [email protected]
Share this article